<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Early gastric cancer: Epidemiology, clinical manifestations, diagnosis, and staging
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Douglas Morgan, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mark Feldman, MD, MACP, AGAF, FACG
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kenneth K Tanabe, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen M Robson, MD, MBA, FACG
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sonali M Shah, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 23, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H4780994">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Early gastric cancer (EGC) is defined as invasive gastric cancer confined to the mucosa or submucosa, irrespective of lymph node metastasis (T1, any N). While EGC is of particular importance for patient care in Eastern Asia, its significance extends to other disciplines and patient populations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Globally, gastric adenocarcinoma, with nearly one million incident cases annually, is the third leading cause of global cancer mortality and the leading cause of infection-associated cancer death [
         <a href="#rid1">
          1-4
         </a>
         ]. EGC accounts for 15 to 57 percent of incident gastric cancer, depending upon the geographic region, and the presence of screening programs. (See
         <a class="local">
          'Epidemiology'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         EGC has driven the development of imaging technologies for early neoplasia detection such as narrow band imaging and autofluorescence imaging. Subsequently, these technologies are being used for conditions throughout the gastrointestinal tract.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The need for better approaches to the treatment of EGC has led to the development of advanced endoscopic resection techniques such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection. (See
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis", section on 'Endoscopic submucosal dissection'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2673.html" rel="external">
          "Overview of endoscopic resection of gastrointestinal tumors"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         As highlighted in the global cancer survival surveillance data (CONCORD-3), survival rates from gastric cancer vary widely, from 10 percent in low-resource settings, to 30 percent in high-resource, low incidence nations, and to nearly 70 percent in eastern Asian countries (Korea, Japan) with gastric cancer screening programs and advanced endoscopic treatment techniques [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Gastric adenocarcinoma, and the major intestinal subtype in particular, progresses through a series of histopathologic stages, from normal mucosa, to chronic gastritis, multifocal atrophic gastritis, intestinal metaplasia, and finally dysplasia and adenocarcinoma. The principal cause of early pan-gastric mucosal inflammation and of chronic gastritis is
         <em>
          Helicobacter pylori
         </em>
         infection, with modulation by host genetics and the host response, diet, and other environmental factors. (See
         <a class="medical medical_review" href="/z/d/html/2617.html" rel="external">
          "Risk factors for gastric cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2514.html" rel="external">
          "Association between Helicobacter pylori infection and gastrointestinal malignancy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/119517.html" rel="external">
          "Gastric cancer: Pathology and molecular pathogenesis"
         </a>
         .)
        </p>
        <p>
         This topic will review the clinical manifestations, diagnosis, and staging of early gastric cancer. The treatment and prognosis of patients with early gastric cancer and the management of patients with advanced gastric cancer are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2473.html" rel="external">
          "Initial systemic therapy for locally advanced unresectable and metastatic esophageal and gastric cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2521.html" rel="external">
          "Local palliation for advanced gastric cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2673.html" rel="external">
          "Overview of endoscopic resection of gastrointestinal tumors"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H142529192">
         <span class="h1">
          DEFINITION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The concept of early gastric cancer (EGC) originated in Japan in 1962. At that time, EGC was defined as a neoplasm that could be successfully treated with surgery. EGC is now defined more specifically as an adenocarcinoma that is restricted to the mucosa or submucosa, irrespective of lymph node metastasis (T1, any N)  (
         <a class="graphic graphic_table graphicRef111190" href="/z/d/graphic/111190.html" rel="external">
          table 1
         </a>
         ). These cancers have a significantly better prognosis (approximately 90 percent five-year survival rate) than do more advanced stages of gastric cancer. (See
         <a class="medical medical_review" href="/z/d/html/2481.html" rel="external">
          "Surgical management of invasive gastric cancer"
         </a>
         .)
        </p>
        <p>
         Importantly, this definition, which has been adopted by the Japan Gastric Cancer Association, the Japan Gastroenterological Endoscopy Society and other international groups, acknowledges that there are a small percentage of patients with EGC who have lymph node involvement [
         <a href="#rid6">
          6-8
         </a>
         ]. These cancers should still be considered EGC, even if they have nodal metastases, as is supported by decades of investigation and data from screening programs [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
         However, nodal metastases can affect treatment in two ways:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who have proven nodal metastases, patients whose pretreatment local staging evaluation indicates a high likelihood of nodal metastases, and patients with T1 disease who are at high risk for nodal metastases (because of tumor size, configuration, or depth of invasion) may not be appropriate candidates for endoscopic resection. Gastrectomy with removal of the regional nodes is the appropriate treatment strategy for such patients. (See
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis", section on 'Endoscopic therapies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with node-positive resected EGC are candidates for adjuvant therapy. (See
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis", section on 'Adjuvant therapies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastric cancer demonstrates marked geographic variability, both regionally and within countries. High-incidence regions include East Asia, mountainous Latin America, and areas in Eastern Europe and Russia [
         <a href="#rid2">
          2
         </a>
         ]. In the United States, the overall incidence rates are modest, and remain greater than those of esophageal cancer. When compared with White Americans, the incidence is higher in all other ethnic and racial groups including Hispanic Americans, Asian Americans, and African Americans [
         <a href="#rid10">
          10
         </a>
         ]. Immigrants from high incidence regions who reside in low incidence regions maintain a higher risk for gastric cancer [
         <a href="#rid11">
          11
         </a>
         ]. For unclear reasons, a rising incidence of gastric cancer has been observed among young adults in the United States [
         <a href="#rid12">
          12,13
         </a>
         ].
        </p>
        <p>
         The incidence of early gastric cancer (EGC), as well as the proportion of gastric adenocarcinomas that are EGCs, vary depending on the population:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In Japan and Eastern Asia, up to one-half of resections for gastric adenocarcinoma represent EGC. In Japan, the proportion rose from 15 to as high as 57 percent with the introduction of screening programs [
         <a href="#rid14">
          14-16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In Korea, 25 to 30 percent of gastric adenocarcinomas are EGCs [
         <a href="#rid17">
          17,18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the United States and Europe, EGCs account for 15 to 21 percent of gastric adenocarcinomas [
         <a href="#rid16">
          16,19-21
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         There are several explanations for the higher incidence of EGC in East Asian versus Western countries: the 5- 10-fold higher incidence rates of gastric cancer in East Asia; the longstanding screening programs, with EGC diagnostic expertise; and lastly, the well-described difference in the interpretation of gastric histology in Eastern versus non-Asian centers. (See
         <a class="local">
          'Histologic classification'
         </a>
         below.)
        </p>
        <p>
         Gastric cancer screening in Japan began in the 1960s with photofluorography, and continues as gastric cancer is a leading cause of cancer mortality [
         <a href="#rid22">
          22
         </a>
         ]. This transitioned to magnification chromoendoscopy with
         <a class="drug drug_general" data-topicid="9088" href="/z/d/drug information/9088.html" rel="external">
          indigo carmine
         </a>
         in experienced centers in eastern Asia [
         <a href="#rid23">
          23
         </a>
         ]. Image-enhanced endoscopy (IEE) technology is rapidly evolving, and along with artificial intelligence (AI), will further enhance the ability to detect advanced lesions [
         <a href="#rid24">
          24,25
         </a>
         ]. Notably, there is variation in screening practices by country and region. Methods used to screen for gastric cancer include endoscopy, radiology, and non-invasive testing (eg,
         <em>
          H. pylori
         </em>
         serology, and serum pepsinogen testing) [
         <a href="#rid22">
          22
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2670.html" rel="external">
          "Chromoendoscopy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2618.html" rel="external">
          "Gastric cancer screening", section on 'Screening modalities'
         </a>
         .)
        </p>
        <p>
         There has been a transition to magnification chromoendoscopy with
         <a class="drug drug_general" data-topicid="9088" href="/z/d/drug information/9088.html" rel="external">
          indigo carmine
         </a>
         spray in experienced centers in eastern Asia [
         <a href="#rid23">
          23
         </a>
         ]. In addition, there is variation in screening practices by country and region. Methods used to screen for gastric cancer include endoscopy, radiology,
         <em>
          H. pylori
         </em>
         serology, and serum pepsinogen testing [
         <a href="#rid22">
          22
         </a>
         ]. Of note, indigo carmine is currently in limited supply in many areas due to a shortage of the raw materials used in its production. (See
         <a class="medical medical_review" href="/z/d/html/2670.html" rel="external">
          "Chromoendoscopy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2618.html" rel="external">
          "Gastric cancer screening", section on 'Screening modalities'
         </a>
         .)
        </p>
        <p>
         There do not appear to be significant differences in the demographic features of patients with EGC between Asian and non-Asian countries [
         <a href="#rid19">
          19,20
         </a>
         ]. The sex and age distributions of EGC are similar in Japan, Europe, and America. The average age at diagnosis is approximately 60 years, and males are more commonly affected than females [
         <a href="#rid20">
          20,26,27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H79221444">
         <span class="h1">
          SCREENING FOR GASTRIC CANCER
         </span>
         <span class="headingEndMark">
          —
         </span>
         Issues related to screening for gastric cancer are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2618.html" rel="external">
          "Gastric cancer screening"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H59427507">
         <span class="h1">
          CLASSIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastric cancers are classified by several systems, according to both histologic and endoscopic findings. In addition, molecular markers may in the future help better define the classification of these tumors, and precision medicine could influence treatment choices and better delineate a patient’s prognosis.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Histologic classification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Differences in gastric histologic interpretation between East Asian and Western pathologists contributes to the higher proportion of early gastric cancers (EGCs) in Asia (see
         <a class="local">
          'Epidemiology'
         </a>
         above). The disagreement centers on the characterization of high-grade dysplasia and intramucosal adenocarcinoma [
         <a href="#rid28">
          28
         </a>
         ]. Western pathologists have typically required invasion of the lamina propria for the diagnosis of cancer, whereas Japanese pathologists have based the diagnosis on cytologic and architectural changes alone, without requiring invasion of the lamina propria. As a result, lesions classified as high-grade dysplasia by Western pathologists may be classified as intramucosal carcinoma by Japanese pathologists. (See
         <a class="medical medical_review" href="/z/d/html/119517.html" rel="external">
          "Gastric cancer: Pathology and molecular pathogenesis", section on 'Histologic classification'
         </a>
         .)
        </p>
        <p>
         The extent of the discrepancy is illustrated by one study, in which four Japanese and four Western pathologists examined 17 gastric biopsies and 18 endoscopic mucosal resection (EMR) specimens from 17 Japanese patients, with findings ranging from reactive atypia to early gastric cancer [
         <a href="#rid29">
          29
         </a>
         ]. There was overall histologic agreement in only 11 of 35 cases (31 percent).
        </p>
        <p>
         However, these differences in classification do not have a significant impact on clinical practice:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with severe dysplasia or EGC are usually managed with endoscopic resection, since both diagnoses are associated with a low risk of lymph node metastases. (See
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis", section on 'Endoscopic submucosal dissection'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Invasion of the lamina propria, which is the threshold for diagnosing cancer among Western pathologists, may be difficult to identify on histology [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         In an attempt to close the gap between the Japanese and Western views and reporting schemes, consensus groups have formulated the Vienna classification of gastrointestinal epithelial neoplasia and the Padova international classification of dysplasia [
         <a href="#rid28">
          28,30
         </a>
         ]. The Vienna classification recognizes the following categories:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Category 1: Negative for neoplasia/dysplasia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Category 2: Indefinite for neoplasia/dysplasia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Category 3: Noninvasive low-grade neoplasia (low-grade adenoma/dysplasia)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Category 4: Noninvasive high-grade neoplasia
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         4.1: High-grade adenoma/dysplasia
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         4.2: Noninvasive carcinoma (carcinoma in situ)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         4.3: Suspicion of invasive carcinoma
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Category 5: Invasive neoplasia
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         5.1: Intramucosal carcinoma (invasion into the lamina propria or muscularis mucosae)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         5.2: Submucosal carcinoma or beyond
        </p>
        <p>
        </p>
        <p>
         The World Health Organization proposed a classification of intraepithelial gastric neoplasias using different terms (negative for dysplasia, indefinite for dysplasia, low-grade and high-grade dysplasia, and carcinoma [invasion into the lamina propria or beyond]) [
         <a href="#rid31">
          31
         </a>
         ]. The various classifications that have been proposed over the years are outlined in the table  (
         <a class="graphic graphic_table graphicRef120177" href="/z/d/graphic/120177.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p>
         Despite these classification systems, the terminology of adenoma (raised lesions) and dysplasia (flat lesions) remains widely used in Western literature and in clinical practice.
        </p>
        <p class="headingAnchor" id="H711100">
         <span class="h3">
          Lauren classification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Histologically, gastric cancers are classified as intestinal (well-, moderately-, poorly-differentiated) or diffuse (undifferentiated, with or without signet ring cells) subtypes based upon the Lauren classification [
         <a href="#rid32">
          32,33
         </a>
         ]. These two types of gastric cancer have distinct morphologic appearances, epidemiology, pathogenesis, and genetic profiles. (See
         <a class="medical medical_review" href="/z/d/html/119517.html" rel="external">
          "Gastric cancer: Pathology and molecular pathogenesis", section on 'Intestinal versus diffuse types'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Macroscopic classification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Various macroscopic classification systems have been developed for gastric adenocarcinoma. One of the more common is the Borrmann system, with classifications of types I-IV for polypoid, fungating, ulcerated, and diffusely infiltrating tumors, respectively  (
         <a class="graphic graphic_figure graphicRef82731" href="/z/d/graphic/82731.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H711133">
         <span class="h3">
          Early gastric cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Classification systems have also been developed specifically for early gastric cancers. While used in Eastern Asia, they are rarely used in the United States and Europe. In particular, the Japanese Macroscopic Classification of Superficial Gastric Carcinoma is widely used in Eastern Asia [
         <a href="#rid34">
          34
         </a>
         ]. The system is based upon visual and endosonographic features and was developed in an attempt to codify the indications and outcomes related to endoscopic mucosal resection [
         <a href="#rid35">
          35
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2673.html" rel="external">
          "Overview of endoscopic resection of gastrointestinal tumors"
         </a>
         .)
        </p>
        <p>
         The Japanese system recognizes four types of early endoluminal cancers  (
         <a class="graphic graphic_table graphicRef71003" href="/z/d/graphic/71003.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_figure graphicRef82731" href="/z/d/graphic/82731.html" rel="external">
          figure 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type I lesions are polypoid or protuberant and are subcategorized as:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ip – pedunculated
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ips/sp – subpedunculated
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Is – sessile
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type II lesions are flat and are further subcategorized as:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         IIa – superficial elevated
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         IIb – flat
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         IIc – flat depressed
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         IIc+IIa lesions – elevated area within a depressed lesion
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         IIa+IIc lesions – depressed area within an elevated lesion
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type III lesions are ulcerated
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type IV lesions are lateral spreading
        </p>
        <p>
        </p>
        <p>
         The Paris system, a newer classification system, was proposed in 2002 and is similar to the Japanese classification system [
         <a href="#rid36">
          36
         </a>
         ]. Superficial lesions (type 0) are classified as polypoid, nonpolypoid, or excavated  (
         <a class="graphic graphic_table graphicRef50239" href="/z/d/graphic/50239.html" rel="external">
          table 4
         </a>
         and
         <a class="graphic graphic_figure graphicRef61277" href="/z/d/graphic/61277.html" rel="external">
          figure 2
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type 0-I lesions are polypoid are subcategorized as:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Type 0-Ip – protruded, pedunculated
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Type 0-Is – protruded, sessile
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type 0-II lesions are nonpolypoid and are subcategorized as:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Type 0-IIa – slightly elevated
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Type 0-IIb – flat
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Type 0-IIc – slightly depressed
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type 0-III lesions are excavated
        </p>
        <p>
        </p>
        <p>
         Type I lesions and type IIa lesions may appear similar [
         <a href="#rid36">
          36
         </a>
         ]. Type I lesions extend above the mucosa more than 2.5 mm (the width of the closed cups of a biopsy forceps). Pathologically, the height of the lesion is more than double the thickness of the adjacent mucosa. Type IIa lesions are slightly elevated, but their height is less than 2.5 mm. Type IIc and type III lesions may also appear similar. Type IIc lesions are slightly depressed with a normal epithelial layer or superficial erosions. Type III lesions are characterized by ulceration, with loss of the mucosa and possibly submucosa.
        </p>
        <p>
         The Paris Workshop confirmed the importance of the Japanese classification for gastric cancer based upon its correlation with risk for nodal metastases [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H795570246">
         <span class="h2">
          Molecular classification
         </span>
         <span class="headingEndMark">
          —
         </span>
         The NIH Cancer Genome Atlas project has redefined the molecular classification of gastric cancer into four subtypes: genomically stable tumors (GS; diffuse histology); tumors with chromosomal instability (CSI; intestinal histology); Epstein–Barr virus positive (EBV; with marked DNA hypermethylation); and microsatellite unstable tumors (MSI; with elevated mutation rates) [
         <a href="#rid37">
          37
         </a>
         ]. The intestinal and diffuse subtypes were confirmed to be the major subtypes, while the EBV and MSI subtypes each accounted for about 10 percent. The improved understanding of the genetic alterations in gastric cancer may in the future also help better define the classification of the EGC tumors, their optimal treatment, and prognosis. In addition, novel biomarkers such as microRNAs may eventually be useful for EGC screening and prognosis, but investigations remain in the early stages [
         <a href="#rid38">
          38-40
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/119517.html" rel="external">
          "Gastric cancer: Pathology and molecular pathogenesis", section on 'Molecular subtyping'
         </a>
         .)
        </p>
        <p>
         The molecular classification of proximal cancers at the esophageal junction and the gastric cardia is underway, and is anticipated to provide insight into the similarities and differences versus distal gastric cancer, and may also identify novel molecular targets for precision medicine treatments [
         <a href="#rid41">
          41,42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2432384314">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The presenting symptoms of early gastric cancer (EGC) are nonspecific. Patients may be asymptomatic or they may present with dyspepsia, mild epigastric pain, nausea, or anorexia. Most patients in East Asia are diagnosed in the context of screening programs. A prodrome of vague upper gastrointestinal symptoms may be present for 6 to 12 months prior to the diagnosis of EGC [
         <a href="#rid43">
          43
         </a>
         ] and occurs in up to 90 to 95 percent of patients who are not detected through screening [
         <a href="#rid19">
          19
         </a>
         ]. Ulcerated lesions may have a longer prodrome of symptoms than protuberant lesions [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p>
         Warning (or alarm) signs or symptoms suggestive of invasive disease in patients with EGC, such as anemia or weight loss, occur in 5 to 15 percent and 4 to 40 percent, respectively [
         <a href="#rid19">
          19
         </a>
         ]. By comparison, weight loss occurs in more than 60 percent of those with advanced gastric adenocarcinoma [
         <a href="#rid44">
          44
         </a>
         ].
        </p>
        <p>
         The nonspecific nature of symptoms in EGC and gastric cancer complicates optimal disease management strategies for patients presenting with dyspepsia [
         <a href="#rid45">
          45
         </a>
         ]. While the prevalence of gastric carcinoma among patients presenting with dyspepsia is low in the United States and other Western countries, there are no reliable clinical or laboratory features to distinguish patients with benign causes of dyspepsia from those with more serious underlying disease. (See
         <a class="medical medical_review" href="/z/d/html/20.html" rel="external">
          "Approach to the adult with dyspepsia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1985745632">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Upper endoscopy with systematic non-targeted biopsies and targeted biopsies of suspicious lesions is the diagnostic procedure of choice for patients with suspected early gastric cancer (EGC). It is more sensitive and specific for the detection of EGC than air contrast
         <a class="drug drug_general" data-topicid="9180" href="/z/d/drug information/9180.html" rel="external">
          barium
         </a>
         radiography  (
         <a class="graphic graphic_diagnosticimage graphicRef61767" href="/z/d/graphic/61767.html" rel="external">
          image 1
         </a>
         ). The sensitivity of barium studies was only 14 percent in one study [
         <a href="#rid46">
          46
         </a>
         ]; in another series, all 15 patients with surgically proven EGC had a negative barium study [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H484506289">
         <span class="h2">
          Upper endoscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Upper endoscopy is central to the diagnosis of EGC, which may appear as a subtle polypoid protrusion, a superficial plaque, mucosal discoloration, a depression, or an ulcer [
         <a href="#rid7">
          7,8,48,49
         </a>
         ]. The gastric cancer miss-rate at endoscopy, or false negative rate, is significant, and can be as high as 25 percent [
         <a href="#rid50">
          50
         </a>
         ]. In one meta-analysis, 26 percent of upper gastrointestinal cancers were missed on endoscopy performed within three years of the patient's diagnosis [
         <a href="#rid50">
          50
         </a>
         ]. Several studies underscore the importance of careful inspection, as measured by endoscopy examination time, suggesting that a minimum duration of seven minutes may be required [
         <a href="#rid51">
          51-53
         </a>
         ]. Station-based protocols (with 22 pictures) have been proposed whereby each area of the stomach is systematically viewed and photographed [
         <a href="#rid48">
          48,54,55
         </a>
         ]. Additional technical aspects of upper endoscopy for patients with suspected EGC include adequate gas insufflation and mucosal cleaning as needed.
        </p>
        <p>
         Image-enhanced endoscopy is indicated for patients at-risk for gastric premalignant lesions, EGC, and gastric cancer, and for use in combination with white-light endoscopy (WLE) [
         <a href="#rid7">
          7,8
         </a>
         ]. Gastric cancer screening programs in Eastern Asia have driven the development of endoscopic imaging technologies with applications throughout the gastrointestinal tract. Image-enhanced endoscopy includes chromoendoscopy (eg,
         <a class="drug drug_general" data-topicid="9088" href="/z/d/drug information/9088.html" rel="external">
          indigo carmine
         </a>
         ), optical and digital technology (eg, NBI), and magnification (eg, optical or digital zoom, near-focus) [
         <a href="#rid56">
          56-58
         </a>
         ]. Magnification chromoendoscopy is routinely used in many referral centers in Eastern Asia. Narrow-band imaging (NBI), including with near-focus imaging and magnification, may have a useful role in the diagnosis of EGC, with studies underway, primarily in East Asia [
         <a href="#rid59">
          59-62
         </a>
         ]. NBI has been shown to have an important role in the detection of gastric intestinal metaplasia, with key features such as the marginal turbid band, light blue crest, and white opaque substance [
         <a href="#rid8">
          8,63,64
         </a>
         ]. The near-focus function, including near-focus NBI, is an emerging alternative in Western countries where magnification endoscopy is not generally available [
         <a href="#rid65">
          65
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2670.html" rel="external">
          "Chromoendoscopy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2646.html" rel="external">
          "Magnification endoscopy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2650.html" rel="external">
          "Barrett's esophagus: Evaluation with optical chromoscopy"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H132294361">
         <span class="h2">
          Gastric biopsy mapping
         </span>
         <span class="headingEndMark">
          —
         </span>
         Systematic gastric biopsies should be considered in at-risk patients and populations. In Western regions, this approach is reasonable for: patients with a family history of gastric cancer; for immigrants from high-incidence areas; patients with known atrophy, intestinal metaplasia or dysplasia; and for patients with clinical or endoscopic parameters warranting vigilance [
         <a href="#rid66">
          66,67
         </a>
         ]. Standard endoscopic biopsy mapping follows the updated Sydney protocol and includes a minimum of two non-targeted biopsies from each of the following sites: antrum (both lesser and greater curvatures), the incisura, and the corpus (both lesser and greater curvatures)  (
         <a class="graphic graphic_figure graphicRef127130" href="/z/d/graphic/127130.html" rel="external">
          figure 3
         </a>
         ) [
         <a href="#rid68">
          68-72
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16636.html" rel="external">
          "Gastric intestinal metaplasia", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
         Additional biopsies may be warranted from the prepyloric region, fundus, and cardia. Targeted biopsies of atypical areas of gastric mucosa are appropriate. (See
         <a class="medical medical_review" href="/z/d/html/2618.html" rel="external">
          "Gastric cancer screening"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2617.html" rel="external">
          "Risk factors for gastric cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16636.html" rel="external">
          "Gastric intestinal metaplasia"
         </a>
         .)
        </p>
        <p>
         In the presence of a gastric ulcer, the site and the number of biopsy specimens are important. The sensitivity for detecting a gastric cancer increases with more biopsies, but the optimal number of biopsies is uncertain. The role of follow-up endoscopy for gastric ulcers not demonstrating gastric cancer on the initial endoscopy with biopsies is in evolution and depends upon the adequacy of biopsies obtained during the initial endoscopy, the appearance of the ulcer, and patient characteristics. (See
         <a class="medical medical_review" href="/z/d/html/26.html" rel="external">
          "Peptic ulcer disease: Clinical manifestations and diagnosis", section on 'Upper endoscopy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2933689829">
         <span class="h1">
          TESTING FOR H. PYLORI
         </span>
         <span class="headingEndMark">
          —
         </span>
         All patients with early gastric cancer should be evaluated for
         <em>
          H. pylori
         </em>
         infection and treated if there is evidence of infection. If the histology is negative for
         <em>
          H. pylori
         </em>
         , the serology is warranted. (See
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis", section on 'Helicobacter pylori infection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3186308429">
         <span class="h1">
          STAGING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastric cancer is staged using the tumor, node, metastasis (TNM) classification system of the American Joint Committee on Cancer (AJCC); the current (eighth edition, 2017) version is outlined in the table  (
         <a class="graphic graphic_table graphicRef111190" href="/z/d/graphic/111190.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid73">
          73
         </a>
         ]. Early gastric cancers (EGCs) are T1 lesions, irrespective of nodal status. (See
         <a class="medical medical_review" href="/z/d/html/2513.html" rel="external">
          "Clinical features, diagnosis, and staging of gastric cancer", section on 'Staging systems'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3546611353">
         <span class="h2">
          Lymph node metastases in EGC
         </span>
         <span class="headingEndMark">
          —
         </span>
         The overall incidence of lymph node metastases (LNM) in clinically staged T1 EGC is 0 to 15 percent in the early literature [
         <a href="#rid74">
          74-78
         </a>
         ]. Although lymph node metastases do not affect the designation of a T1 EGC tumor, they have implications for therapy. (See
         <a class="medical medical_review" href="/z/d/html/2523.html" rel="external">
          "Adjuvant and neoadjuvant treatment of gastric cancer"
         </a>
         .)
        </p>
        <p>
         Tumor characteristics inform the risk of lymph node metastases and have helped refine guidelines for selecting patients for endoscopic resection [
         <a href="#rid79">
          79,80
         </a>
         ]. Factors associated with lymph node metastases include larger tumor size, ulceration, diffuse (undifferentiated) or mixed (intestinal/undifferentiated) type histology, depth of invasion, and submucosal or lymphovascular invasion [
         <a href="#rid76">
          76,78,81,82
         </a>
         ]. Thus, patients with EGC who are typically appropriate for endoscopic resection include those with small (&lt;2 cm), nonulcerated, mucosal cancers, and possibly those with submucosal tumors that are small (&lt;2 to 3 cm), well differentiated, and lack lymphovascular invasion. Accurate endoscopic estimation of lesion size is an important factor, and underestimation of size may affect the complete and curative resection rates [
         <a href="#rid83">
          83
         </a>
         ].The standard and expanded criteria for determining risk of LNM are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis", section on 'Standard and expanded criteria for endoscopic resection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1833258016">
         <span class="h2">
          Staging work-up
         </span>
         <span class="headingEndMark">
          —
         </span>
         The findings on endoscopy can predict tumor stage. In one study of 2105 patients, endoscopic findings were 78 percent accurate for predicting the depth of invasion of EGC [
         <a href="#rid84">
          84
         </a>
         ]. Findings associated with mucosal disease included smooth surface protrusion or depression, slight marginal elevation, and smooth tapering of converging folds. Findings suggestive of submucosal disease included an irregular surface, marked marginal elevation, and clubbing, abrupt cutting, or fusion of converging folds. (See
         <a class="medical medical_review" href="/z/d/html/2513.html" rel="external">
          "Clinical features, diagnosis, and staging of gastric cancer", section on 'Staging evaluation'
         </a>
         .)
        </p>
        <p>
         However, staging may be more accurately accomplished using a combination of endoscopic resection and endoscopic ultrasonography (EUS).
        </p>
        <p class="headingAnchor" id="H885226022">
         <span class="h3">
          Endoscopic resection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endoscopic resection with endoscopic submucosal dissection (ESD) is considered both a staging procedure and a treatment for EGC [
         <a href="#rid7">
          7,85
         </a>
         ]. ESD is indicated for high grade dysplasia (HGD) and in some cases for low-grade dysplasia with visible abnormalities [
         <a href="#rid86">
          86
         </a>
         ]. Upstaging of HGD and EGC is commonly observed with ESD en bloc resection [
         <a href="#rid87">
          87,88
         </a>
         ]. En bloc resection permits T staging of the tumor and does not preclude subsequent gastrectomy if the resection is incomplete or if there are unfavorable histologic findings. The presence of unfavorable histologic findings suggests a higher incidence of lymph node metastases, and therefore, indicates that an operative approach to treatment is preferred. In referral centers in Eastern Asia and elsewhere, strict criteria are used to determine the appropriateness of endoscopic resection for EGC. (See
         <a class="medical medical_review" href="/z/d/html/2673.html" rel="external">
          "Overview of endoscopic resection of gastrointestinal tumors", section on 'Gastric cancer'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis", section on 'Standard and expanded criteria for endoscopic resection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2423978496">
         <span class="h3">
          Endoscopic ultrasonography
         </span>
         <span class="headingEndMark">
          —
         </span>
         EUS is thought to be a reliable nonsurgical method available for evaluating the depth of invasion of gastric cancer, particularly for T1 lesions [
         <a href="#rid89">
          89-91
         </a>
         ]. In a study of 955 patients with suspected EGC, EUS staging accuracy was compared with surgical or endoscopic resection [
         <a href="#rid92">
          92
         </a>
         ]. EUS correctly identified the T stage in 644 patients (67 percent). The accuracy of miniprobe EUS was significantly higher than radial EUS (80 versus 60 percent).
        </p>
        <p>
         Regional lymph node involvement may also be detected by EUS. The definition of regional versus extraregional nodes for gastric cancer depends on location [
         <a href="#rid93">
          93
         </a>
         ]. Regional nodes for tumors involving different parts of the stomach are depicted in the figure  (
         <a class="graphic graphic_figure graphicRef111191" href="/z/d/graphic/111191.html" rel="external">
          figure 4
         </a>
         ). Involvement of other intraabdominal nodal groups (ie, pancreatoduodenal, retropancreatic, peripancreatic, superior mesenteric, middle colic, paraaortic, and retroperitoneal) is classified as distant metastases [
         <a href="#rid73">
          73
         </a>
         ].
        </p>
        <p>
         Although EUS may detect enlargement of regional nodes, the differentiation between benign (reactive) perigastric inflammation and nodal metastasis can be difficult. EUS-guided fine-needle aspiration of suspicious nodes and regional areas adds to the accuracy of nodal staging.
        </p>
        <p>
         EUS has become a valuable tool for the selection of patients with EGC who are suitable for endoscopic resection [
         <a href="#rid94">
          94-97
         </a>
         ]. However, certain features (eg, mid-gastric location, poorly differentiated tumors) may lead to incorrect staging [
         <a href="#rid98">
          98
         </a>
         ]. For this reason, in many areas of Eastern Asia, endoscopic resection (ESD) rather than EUS is considered the primary staging procedure for EGC. By contrast, in Western countries, EUS is more commonly recommended for all patients without evidence of metastatic disease [
         <a href="#rid99">
          99
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H711495">
         <span class="h3">
          Other tests
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other staging procedures, such as CT and positron emission tomography with fluorodeoxyglucose (FDG-PET) may also be used selectively [
         <a href="#rid99">
          99
         </a>
         ]. These procedures are used more commonly in Western referral centers. (See
         <a class="medical medical_review" href="/z/d/html/2513.html" rel="external">
          "Clinical features, diagnosis, and staging of gastric cancer", section on 'Computed tomography scan in all patients'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2513.html" rel="external">
          "Clinical features, diagnosis, and staging of gastric cancer", section on '18-fluorodeoxyglucose positron emission tomography scan'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3022655411">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/114875.html" rel="external">
          "Society guideline links: Gastric cancer"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H30746957">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/83156.html" rel="external">
          "Patient education: Stomach cancer (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Early gastric cancer (EGC) is defined as adenocarcinoma limited to the gastric mucosa or submucosa, regardless of involvement of the regional lymph nodes (T1, any N). (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         EGC is an important subset of gastric adenocarcinoma. Gastric cancer screening programs in Eastern Asia have prompted the development of advanced imaging technologies and endoscopic resection modalities, which are subsequently being used for other conditions in the gastrointestinal tract.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The presenting symptoms of EGC are nonspecific. Patients may be asymptomatic or they may present with dyspepsia, mild epigastric pain, nausea, or anorexia. (See
         <a class="local">
          'Classification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         White light endoscopy in combination with an image-enhanced endoscopic technique such as magnification chromoendoscopy or narrow band imaging is performed with a gastric mucosal biopsy protocol to make the diagnosis of EGC. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Staging of EGC may be accomplished using a combination of endoscopic resection with endoscopic submucosal dissection (ESD) and endoscopic ultrasound (EUS). In clinical practice, the use of EUS is variable. (See
         <a class="local">
          'Staging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Factors associated with lymph node metastases include larger tumor size, ulceration, diffuse (undifferentiated) or mixed (intestinal/undifferentiated) type histology, depth of invasion, and submucosal or lymphovascular invasion. Although lymph node metastases do not affect the designation of a T1 EGC tumor, they have implications for therapy. (See
         <a class="local">
          'Lymph node metastases in EGC'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis"
         </a>
         .)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Plummer M, de Martel C, Vignat J, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health 2016; 4:e609.
          </a>
         </li>
         <li class="breakAll">
          Global cancer statistics available online from the IARC GLOBOCAN Database https://gco.iarc.fr/ (Accessed on January 04, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Martel C, Georges D, Bray F, et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health 2020; 8:e180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coates MM, Kintu A, Gupta N, et al. Burden of non-communicable diseases from infectious causes in 2017: a modelling study. Lancet Glob Health 2020; 8:e1489.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018; 391:1023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hatta W, Gotoda T, Koike T, Masamune A. History and future perspectives in Japanese guidelines for endoscopic resection of early gastric cancer. Dig Endosc 2020; 32:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yao K, Uedo N, Kamada T, et al. Guidelines for endoscopic diagnosis of early gastric cancer. Dig Endosc 2020; 32:663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waddingham W, Nieuwenburg SAV, Carlson S, et al. Recent advances in the detection and management of early gastric cancer and its precursors. Frontline Gastroenterol 2021; 12:322.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alfaro EE, Lauwers GY. Early gastric neoplasia: diagnosis and implications. Adv Anat Pathol 2011; 18:268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin 2023; 73:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pabla BS, Shah SC, Corral JE, Morgan DR. Increased Incidence and Mortality of Gastric Cancer in Immigrant Populations from High to Low Regions of Incidence: A Systematic Review and Meta-Analysis. Clin Gastroenterol Hepatol 2020; 18:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anderson WF, Rabkin CS, Turner N, et al. The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites. J Natl Cancer Inst 2018; 110:608.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camargo MC, Anderson WF, King JB, et al. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut 2011; 60:1644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shimizu S, Tada M, Kawai K. Early gastric cancer: its surveillance and natural course. Endoscopy 1995; 27:27.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maehara Y, Orita H, Okuyama T, et al. Predictors of lymph node metastasis in early gastric cancer. Br J Surg 1992; 79:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Noguchi Y, Yoshikawa T, Tsuburaya A, et al. Is gastric carcinoma different between Japan and the United States? Cancer 2000; 89:2237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee HJ, Yang HK, Ahn YO. Gastric cancer in Korea. Gastric Cancer 2002; 5:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kang HJ, Kim DH, Jeon TY, et al. Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection. Gastrointest Endosc 2010; 72:508.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Everett SM, Axon AT. Early gastric cancer in Europe. Gut 1997; 41:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eckardt VF, Giessler W, Kanzler G, et al. Clinical and morphological characteristics of early gastric cancer. A case-control study. Gastroenterology 1990; 98:708.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Everett SM, Axon AT. Early gastric cancer: disease or pseudo-disease? Lancet 1998; 351:1350.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamashima C, Shibuya D, Yamazaki H, et al. The Japanese guidelines for gastric cancer screening. Jpn J Clin Oncol 2008; 38:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pittayanon R, Rerknimitr R. Role of digital chromoendoscopy and confocal laser endomicroscopy for gastric intestinal metaplasia and cancer surveillance. World J Gastrointest Endosc 2012; 4:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Frazzoni L, Arribas J, Antonelli G, et al. Endoscopists' diagnostic accuracy in detecting upper gastrointestinal neoplasia in the framework of artificial intelligence studies. Endoscopy 2022; 54:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pannala R, Krishnan K, Melson J, et al. Artificial intelligence in gastrointestinal endoscopy. VideoGIE 2020; 5:598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Biasco G, Paganelli GM, Azzaroni D, et al. Early gastric cancer in Italy. Clinical and pathological observations on 80 cases. Dig Dis Sci 1987; 32:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans DM, Craven JL, Murphy F, Cleary BK. Comparison of "early gastric cancer" in Britain and Japan. Gut 1978; 19:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schlemper RJ, Riddell RH, Kato Y, et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schlemper RJ, Itabashi M, Kato Y, et al. Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet 1997; 349:1725.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rugge M, Correa P, Dixon MF, et al. Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000; 24:167.
          </a>
         </li>
         <li class="breakAll">
          Kushima R, Lauwers GY, Rugge M. Gastric Dysplasia. In: WHO Classification of Tumours: Digestive Systemic Tumours, 5th, WHO Classification of Tumours Editorial Board (Ed), International Agency for Research on Cancer, Lyon 2019. p.71.
         </li>
         <li>
          <a class="nounderline abstract_t">
           LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand 1965; 64:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laurén PA, Nevalainen TJ. Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer 1993; 71:2926.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Japanese Gastric Cancer Association . Japanese Classification of Gastric Carcinoma - 2nd English Edition -. Gastric Cancer 1998; 1:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           The general rules for The gastric cancer study in surgery. Jpn J Surg 1973; 3:61.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc 2003; 58:S3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014; 513:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhu C, Ren C, Han J, et al. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br J Cancer 2014; 110:2291.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Asada K, Nakajima T, Shimazu T, et al. Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study. Gut 2015; 64:388.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li B, Rao N, Liu D, et al. Analysis of connection networks among miRNAs differentially expressed in early gastric cancer for disclosing some biological features of disease development. Gene 2014; 548:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cancer Genome Atlas Research Network, Analysis Working Group: Asan University, BC Cancer Agency, et al. Integrated genomic characterization of oesophageal carcinoma. Nature 2017; 541:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Imamura Y, Watanabe M, Oki E, et al. Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study. Ann Gastroenterol Surg 2021; 5:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Craanen ME, Dekker W, Ferwerda J, et al. Early gastric cancer: a clinicopathologic study. J Clin Gastroenterol 1991; 13:274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wanebo HJ, Kennedy BJ, Chmiel J, et al. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993; 218:583.
          </a>
         </li>
         <li class="breakAll">
          Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders. In: Rome III: The Functional Gastrointestinal Disorders, 3rd ed, Drossman DA, Corazziari E, Delvaux M, et al (Eds), Degnon Associates, Inc, McLean, Virginia 2006. p.419.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Longo WE, Zucker KA, Zdon MJ, Modlin IM. Detection of early gastric cancer in an aggressive endoscopy unit. Am Surg 1989; 55:100.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ballantyne KC, Morris DL, Jones JA, et al. Accuracy of identification of early gastric cancer. Br J Surg 1987; 74:618.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yao K. The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol 2013; 26:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981; 11:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hosokawa O, Hattori M, Douden K, et al. Difference in accuracy between gastroscopy and colonoscopy for detection of cancer. Hepatogastroenterology 2007; 54:442.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Teh JL, Tan JR, Lau LJ, et al. Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy. Clin Gastroenterol Hepatol 2015; 13:480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kawamura T, Wada H, Sakiyama N, et al. Examination time as a quality indicator of screening upper gastrointestinal endoscopy for asymptomatic examinees. Dig Endosc 2017; 29:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park JM, Huo SM, Lee HH, et al. Longer Observation Time Increases Proportion of Neoplasms Detected by Esophagogastroduodenoscopy. Gastroenterology 2017; 153:460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ang TL, Khor CJ, Gotoda T. Diagnosis and endoscopic resection of early gastric cancer. Singapore Med J 2010; 51:93.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Emura F, Gralnek I, Baron TH. Improving early detection of gastric cancer: a novel systematic alphanumeric-coded endoscopic approach. Rev Gastroenterol Peru 2013; 33:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li HY, Dai J, Xue HB, et al. Application of magnifying endoscopy with narrow-band imaging in diagnosing gastric lesions: a prospective study. Gastrointest Endosc 2012; 76:1124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Subramanian V, Ragunath K. Advanced endoscopic imaging: a review of commercially available technologies. Clin Gastroenterol Hepatol 2014; 12:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yao K, Doyama H, Gotoda T, et al. Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study. Gastric Cancer 2014; 17:669.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurumi H, Nonaka K, Ikebuchi Y, et al. Fundamentals, Diagnostic Capabilities and Perspective of Narrow Band Imaging for Early Gastric Cancer. J Clin Med 2021; 10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshida N, Doyama H, Yano T, et al. Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging. Gut 2021; 70:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hu H, Gong L, Dong D, et al. Identifying early gastric cancer under magnifying narrow-band images with deep learning: a multicenter study. Gastrointest Endosc 2021; 93:1333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matsumoto K, Ueyama H, Yao T, et al. Diagnostic limitations of magnifying endoscopy with narrow-band imaging in early gastric cancer. Endosc Int Open 2020; 8:E1233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Desai M, Boregowda U, Srinivasan S, et al. Narrow band imaging for detection of gastric intestinal metaplasia and dysplasia: A systematic review and meta-analysis. J Gastroenterol Hepatol 2021; 36:2038.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Esposito G, Pimentel-Nunes P, Angeletti S, et al. Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study. Endoscopy 2019; 51:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kakushima N, Yoshida N, Doyama H, et al. Near-focus magnification and second-generation narrow-band imaging for early gastric cancer in a randomized trial. J Gastroenterol 2020; 55:1127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim GH, Liang PS, Bang SJ, Hwang JH. Screening and surveillance for gastric cancer in the United States: Is it needed? Gastrointest Endosc 2016; 84:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taylor VM, Ko LK, Hwang JH, et al. Gastric cancer in asian american populations: a neglected health disparity. Asian Pac J Cancer Prev 2014; 15:10565.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Correa P, Piazuelo MB, Wilson KT. Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol 2010; 105:493.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Vries AC, Haringsma J, de Vries RA, et al. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions. Helicobacter 2010; 15:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yantiss RK, Odze RD. Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract. Am J Gastroenterol 2009; 104:774.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dinis-Ribeiro M, Areia M, de Vries AC, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy 2012; 44:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161.
          </a>
         </li>
         <li class="breakAll">
          Ajani JA, In H, Sano T, et al. Stomach. In: AJCC Cancer Staging Manual, 8th ed, Amin MB (Ed), AJCC, Chicago 2017. p.203.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seto Y, Nagawa H, Muto T. Impact of lymph node metastasis on survival with early gastric cancer. World J Surg 1997; 21:186.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Folli S, Dente M, Dell'Amore D, et al. Early gastric cancer: prognostic factors in 223 patients. Br J Surg 1995; 82:952.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roviello F, Rossi S, Marrelli D, et al. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol 2006; 94:275.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nakamura K, Morisaki T, Sugitani A, et al. An early gastric carcinoma treatment strategy based on analysis of lymph node metastasis. Cancer 1999; 85:1500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000; 3:219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mihmanli M, Ilhan E, Idiz UO, et al. Recent developments and innovations in gastric cancer. World J Gastroenterol 2016; 22:4307.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abdelfatah MM, Barakat M, Lee H, et al. The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis. Gastrointest Endosc 2018; 87:338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee IS, Yook JH, Park YS, et al. Suitability of endoscopic submucosal dissection for treatment of submucosal gastric cancers. Br J Surg 2013; 100:668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fujikawa H, Sakamaki K, Kawabe T, et al. A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment. Ann Surg Oncol 2015; 22:2317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shim CN, Song MK, Kang DR, et al. Size discrepancy between endoscopic size and pathologic size is not negligible in endoscopic resection for early gastric cancer. Surg Endosc 2014; 28:2199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi J, Kim SG, Im JP, et al. Endoscopic prediction of tumor invasion depth in early gastric cancer. Gastrointest Endosc 2011; 73:917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cheung DY, Park SH. How to Interpret the Pathological Report before and after Endoscopic Submucosal Dissection of Early Gastric Cancer. Clin Endosc 2016; 49:327.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Banks M, Graham D, Jansen M, et al. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 2019; 68:1545.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ryu DG, Choi CW, Kang DH, et al. Pathologic outcomes of endoscopic submucosal dissection for gastric epithelial neoplasia. Medicine (Baltimore) 2018; 97:e11802.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ryu DG, Choi CW, Kang DH, et al. Clinical outcomes of endoscopic submucosa dissection for high-grade dysplasia from endoscopic forceps biopsy. Gastric Cancer 2017; 20:671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mocellin S, Pasquali S. Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer. Cochrane Database Syst Rev 2015; :CD009944.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JY, Choi IJ, Kim CG, et al. Therapeutic Decision-Making Using Endoscopic Ultrasonography in Endoscopic Treatment of Early Gastric Cancer. Gut Liver 2016; 10:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsujii Y, Kato M, Inoue T, et al. Integrated diagnostic strategy for the invasion depth of early gastric cancer by conventional endoscopy and EUS. Gastrointest Endosc 2015; 82:452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi J, Kim SG, Im JP, et al. Comparison of endoscopic ultrasonography and conventional endoscopy for prediction of depth of tumor invasion in early gastric cancer. Endoscopy 2010; 42:705.
          </a>
         </li>
         <li class="breakAll">
          American Joint Committee on Cancer Staging Manual, 7th ed, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York 2010. p.117.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shi D, Xi XX. Factors Affecting the Accuracy of Endoscopic Ultrasonography in the Diagnosis of Early Gastric Cancer Invasion Depth: A Meta-analysis. Gastroenterol Res Pract 2019; 2019:8241381.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li X, Zhu M, Wang Y, et al. Diagnostic Efficacy and Decision-Making Role of Preoperative Endoscopic Ultrasonography in Early Gastric Cancer. Front Med (Lausanne) 2021; 8:761295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuroki K, Oka S, Tanaka S, et al. Clinical significance of endoscopic ultrasonography in diagnosing invasion depth of early gastric cancer prior to endoscopic submucosal dissection. Gastric Cancer 2021; 24:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamada K, Itoh T, Kawaura K, et al. Examination of Endoscopic Ultrasonographic Diagnosis for the Depth of Early Gastric Cancer. J Clin Med Res 2021; 13:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim JH, Song KS, Youn YH, et al. Clinicopathologic factors influence accurate endosonographic assessment for early gastric cancer. Gastrointest Endosc 2007; 66:901.
          </a>
         </li>
         <li class="breakAll">
          http://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf (Accessed on September 17, 2019).
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2520 Version 42.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27470177" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Global burden of cancers attributable to infections in 2012: a synthetic analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27470177" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Global burden of cancers attributable to infections in 2012: a synthetic analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31862245" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33098769" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29395269" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31529716" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : History and future perspectives in Japanese guidelines for endoscopic resection of early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32275342" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Guidelines for endoscopic diagnosis of early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34249318" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Recent advances in the detection and management of early gastric cancer and its precursors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21654358" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Early gastric neoplasia: diagnosis and implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36633525" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Cancer statistics, 2023.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31154030" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Increased Incidence and Mortality of Gastric Cancer in Immigrant Populations from High to Low Regions of Incidence: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29361173" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21613644" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7601031" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Early gastric cancer: its surveillance and natural course.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1555092" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Predictors of lymph node metastasis in early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11147594" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Is gastric carcinoma different between Japan and the United States?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12378346" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Gastric cancer in Korea.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20554277" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Lymph node metastasis from intestinal-type early gastric cancer: experience in a single institution and reassessment of the extended criteria for endoscopic submucosal dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9301490" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Early gastric cancer in Europe.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2298372" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Clinical and morphological characteristics of early gastric cancer. A case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9643813" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Early gastric cancer: disease or pseudo-disease?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18344316" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : The Japanese guidelines for gastric cancer screening.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23189218" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Role of digital chromoendoscopy and confocal laser endomicroscopy for gastric intestinal metaplasia and cancer surveillance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33951743" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Endoscopists' diagnostic accuracy in detecting upper gastrointestinal neoplasia in the framework of artificial intelligence studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33319126" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Artificial intelligence in gastrointestinal endoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3803141" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Early gastric cancer in Italy. Clinical and pathological observations on 80 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/624498" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Comparison of "early gastric cancer" in Britain and Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10896917" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The Vienna classification of gastrointestinal epithelial neoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9193382" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10680883" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Gastric dysplasia: the Padova international classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10680883" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Gastric dysplasia: the Padova international classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14320675" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8490820" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11957040" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Japanese Classification of Gastric Carcinoma - 2nd English Edition -
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4803902" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The general rules for The gastric cancer study in surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14652541" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25079317" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Comprehensive molecular characterization of gastric adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24595006" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25379950" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25014139" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Analysis of connection networks among miRNAs differentially expressed in early gastric cancer for disclosing some biological features of disease development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28052061" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Integrated genomic characterization of oesophageal carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33532680" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Esophagogastric junction adenocarcinoma shares characteristics with gastric adenocarcinoma: Literature review and retrospective multicenter cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2066544" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Early gastric cancer: a clinicopathologic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8239772" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Cancer of the stomach. A patient care study by the American College of Surgeons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8239772" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Cancer of the stomach. A patient care study by the American College of Surgeons.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2916797" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Detection of early gastric cancer in an aggressive endoscopy unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3620874" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Accuracy of identification of early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24714327" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The endoscopic diagnosis of early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7300058" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17523293" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Difference in accuracy between gastroscopy and colonoscopy for detection of cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25117772" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Longer examination time improves detection of gastric cancer during diagnostic upper gastrointestinal endoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28066945" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Examination time as a quality indicator of screening upper gastrointestinal endoscopy for asymptomatic examinees.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28501581" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Longer Observation Time Increases Proportion of Neoplasms Detected by Esophagogastroduodenoscopy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20358145" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Diagnosis and endoscopic resection of early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23539057" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Improving early detection of gastric cancer: a novel systematic alphanumeric-coded endoscopic approach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23025977" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Application of magnifying endoscopy with narrow-band imaging in diagnosing gastric lesions: a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23811245" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Advanced endoscopic imaging: a review of commercially available technologies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24407989" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Diagnostic performance and limitations of magnifying narrow-band imaging in screening endoscopy of early gastric cancer: a prospective multicenter feasibility study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34209939" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Fundamentals, Diagnostic Capabilities and Perspective of Narrow Band Imaging for Early Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32241898" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Early gastric cancer detection in high-risk patients: a multicentre randomised controlled trial on the effect of second-generation narrow band imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33248070" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Identifying early gastric cancer under magnifying narrow-band images with deep learning: a multicenter study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33015324" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Diagnostic limitations of magnifying endoscopy with narrow-band imaging in early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34090306" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Narrow band imaging for detection of gastric intestinal metaplasia and dysplasia: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30577062" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33021688" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Near-focus magnification and second-generation narrow-band imaging for early gastric cancer in a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26940296" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Screening and surveillance for gastric cancer in the United States: Is it needed?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25605140" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Gastric cancer in asian american populations: a neglected health disparity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20203636" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Pathology of gastric intestinal metaplasia: clinical implications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20633186" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19209164" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Optimal approach to obtaining mucosal biopsies for assessment of inflammatory disorders of the gastrointestinal tract.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22198778" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8827022" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8827022" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8995076" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Impact of lymph node metastasis on survival with early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7648118" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Early gastric cancer: prognostic factors in 223 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16917863" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10193939" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : An early gastric carcinoma treatment strategy based on analysis of lymph node metastasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11984739" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27158199" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Recent developments and innovations in gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28966062" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : The incidence of lymph node metastasis in early gastric cancer according to the expanded criteria in comparison with the absolute criteria of the Japanese Gastric Cancer Association: a systematic review of the literature and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23334982" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Suitability of endoscopic submucosal dissection for treatment of submucosal gastric cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25752893" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : A New Statistical Model Identified Two-thirds of Clinical T1 Gastric Cancers as Possible Candidates for Endoscopic Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24519032" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Size discrepancy between endoscopic size and pathologic size is not negligible in endoscopic resection for early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21316050" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Endoscopic prediction of tumor invasion depth in early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27456609" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : How to Interpret the Pathological Report before and after Endoscopic Submucosal Dissection of Early Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31278206" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30113468" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Pathologic outcomes of endoscopic submucosal dissection for gastric epithelial neoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27822683" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Clinical outcomes of endoscopic submucosa dissection for high-grade dysplasia from endoscopic forceps biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25914908" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Diagnostic accuracy of endoscopic ultrasonography (EUS) for the preoperative locoregional staging of primary gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26087792" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Therapeutic Decision-Making Using Endoscopic Ultrasonography in Endoscopic Treatment of Early Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25841580" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Integrated diagnostic strategy for the invasion depth of early gastric cancer by conventional endoscopy and EUS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20652857" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Comparison of endoscopic ultrasonography and conventional endoscopy for prediction of depth of tumor invasion in early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20652857" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Comparison of endoscopic ultrasonography and conventional endoscopy for prediction of depth of tumor invasion in early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31933632" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Factors Affecting the Accuracy of Endoscopic Ultrasonography in the Diagnosis of Early Gastric Cancer Invasion Depth: A Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34746194" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Diagnostic Efficacy and Decision-Making Role of Preoperative Endoscopic Ultrasonography in Early Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32572791" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Clinical significance of endoscopic ultrasonography in diagnosing invasion depth of early gastric cancer prior to endoscopic submucosal dissection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34007360" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Examination of Endoscopic Ultrasonographic Diagnosis for the Depth of Early Gastric Cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17963876" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Clinicopathologic factors influence accurate endosonographic assessment for early gastric cancer.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
